These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35078111)

  • 1. Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice.
    Yoshikawa E; Tamiya S; Inoue Y; Suzuki K; Yoshioka Y
    Biochem Biophys Res Commun; 2022 Feb; 594():81-87. PubMed ID: 35078111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1α and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice.
    Tamiya S; Yoshikawa E; Ogura M; Kuroda E; Suzuki K; Yoshioka Y
    Microbiol Spectr; 2021 Dec; 9(3):e0158821. PubMed ID: 34937175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the pathogenicity of Mycoplasma pneumoniae: Focus on community-acquired respiratory distress syndrome toxins.
    Xu N; Fan L; Li L; Guo Y
    Microb Pathog; 2024 Oct; 195():106865. PubMed ID: 39153578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.
    Kannan TR; Musatovova O; Balasubramanian S; Cagle M; Jordan JL; Krunkosky TM; Davis A; Hardy RD; Baseman JB
    Mol Microbiol; 2010 Jun; 76(5):1127-41. PubMed ID: 20199607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma.
    Peters J; Singh H; Brooks EG; Diaz J; Kannan TR; Coalson JJ; Baseman JG; Cagle M; Baseman JB
    Chest; 2011 Aug; 140(2):401-407. PubMed ID: 21622549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.
    Hardy RD; Coalson JJ; Peters J; Chaparro A; Techasaensiri C; Cantwell AM; Kannan TR; Baseman JB; Dube PH
    PLoS One; 2009 Oct; 4(10):e7562. PubMed ID: 19859545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.
    Kannan TR; Coalson JJ; Cagle M; Musatovova O; Hardy RD; Baseman JB
    J Infect Dis; 2011 Nov; 204(10):1596-604. PubMed ID: 21957154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycoplasma pneumoniae toxin of community-acquired respiratory distress syndrome (CARDS) promotes autophagy of THP-1 cells and activates NLRP3 inflammasomes].
    Xia W; Dai X; Wu L; Yi C; Zou Z; Ding L; Xi Y; Xu H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1076-1082. PubMed ID: 33325360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.
    Medina JL; Coalson JJ; Brooks EG; Winter VT; Chaparro A; Principe MF; Kannan TR; Baseman JB; Dube PH
    Am J Respir Cell Mol Biol; 2012 Jun; 46(6):815-22. PubMed ID: 22281984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High co-expression of TNF-α and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia.
    Li G; Fan L; Wang Y; Huang L; Wang M; Zhu C; Hao C; Ji W; Liang H; Yan Y; Chen Z
    Mol Med; 2019 Aug; 25(1):38. PubMed ID: 31399022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination using inactivated Mycoplasma pneumoniae induces detrimental infiltration of neutrophils after subsequent infection in mice.
    Tamiya S; Yoshikawa E; Ogura M; Kuroda E; Suzuki K; Yoshioka Y
    Vaccine; 2020 Jul; 38(32):4979-4987. PubMed ID: 32536549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.
    Techasaensiri C; Tagliabue C; Cagle M; Iranpour P; Katz K; Kannan TR; Coalson JJ; Baseman JB; Hardy RD
    Am J Respir Crit Care Med; 2010 Sep; 182(6):797-804. PubMed ID: 20508214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the CARDS toxin and its fragment for the serodiagnosis of Mycoplasma pneumoniae infections.
    Xue G; Zhao H; Yan C; Li S; Cui J; Feng Y; Xie X; Yuan J
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1705-1711. PubMed ID: 33733396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.
    Maselli DJ; Medina JL; Brooks EG; Coalson JJ; Kannan TR; Winter VT; Principe M; Cagle MP; Baseman JB; Dube PH; Peters JI
    Am J Respir Cell Mol Biol; 2018 Feb; 58(2):253-260. PubMed ID: 28915064
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ramasamy K; Balasubramanian S; Manickam K; Pandranki L; Taylor AB; Hart PJ; Baseman JB; Kannan TR
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362229
    [No Abstract]   [Full Text] [Related]  

  • 16. Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells.
    Somarajan SR; Al-Asadi F; Ramasamy K; Pandranki L; Baseman JB; Kannan TR
    mBio; 2014 Aug; 5(4):. PubMed ID: 25139904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background.
    Chu HW; Breed R; Rino JG; Harbeck RJ; Sills MR; Martin RJ
    Microbes Infect; 2006 Jun; 8(7):1764-72. PubMed ID: 16713727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in studies on Mycoplasma pneumoniae-produced community-acquired respiratory distress syndrome toxin].
    Li XJ; Li SX; Chen ZM
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):555-7. PubMed ID: 24267145
    [No Abstract]   [Full Text] [Related]  

  • 19. T-B cell epitope peptides induce protective immunity against Mycoplasma pneumoniae respiratory tract infection in BALB/c mice.
    Chen Y; Wu Y; Qin L; Yu L; Luo H; Li Y; Wang K; Chen L; Zhu C; He J; Zeng Y; Huang L; You X
    Immunobiology; 2021 May; 226(3):152077. PubMed ID: 33831654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice].
    Zhu C; Yu M; Gao S; Zeng Y; You X; Wu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):585-8. PubMed ID: 23746241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.